Skip to main content

Trulieve Cannabis Corp

For the period ended Jun 30, 2024. Filed Aug 6, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 6, 2024

TRLV$11.09+0.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(in thousands)

Six Months EndedJune 30,
20242023
Cash flows from operating activities
Net loss$(37,159)$(472,503)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization55,83156,610
Depreciation included in cost of goods sold26,79330,945
Impairment and disposal of long-lived assets, net of recoveries(127)6,689
Impairment of goodwill—307,590
Amortization of operating lease right of use assets5,3615,260
Share-based compensation10,1102,876
Allowance for credit losses4,433350
Deferred income tax expense (benefit)3,518(12,236)
Loss from disposal of discontinued operations—69,275
Other non-cash changes1,1773,334
Changes in operating assets and liabilities:
Inventories5,01040,333
Accounts receivable747(664)
Prepaid expenses and other current assets(5,754)4,957
Other assets(5,034)1,704
Accounts payable and accrued liabilities(244)(4,338)
Income tax receivable / payable(4,838)(49,728)
Other liabilities202(15,254)
Operating lease liabilities(4,312)(4,876)
Deferred revenue2,980(3,782)
Uncertain tax position liabilities152,75211,179
Other long-term liabilities(2,447)(783)
Proceeds received from insurance for operating expenses1,473—
Net cash provided by (used in) operating activities210,472(23,062)
Cash flows from investing activities
Purchases of property and equipment(42,104)(24,720)
Capitalized interest318(795)
Purchases of internal use software(11,510)(4,383)
Proceeds received from insurance recoveries on property and equipment527—
Cash paid for licenses(500)(3,971)
Payments received from notes receivable581358
Proceeds from disposal activities7488,193
Net cash used in investing activities(51,940)(25,318)
Cash flows from financing activities
Proceeds from non-controlling interest holders' subscription3,000—
Proceeds from equity exercises210—
Payments on notes payable(2,444)(4,828)
Payments on finance lease obligations(3,605)(3,895)
Payments on construction finance liabilities(1,630)(562)
Payments for taxes related to net share settlement of equity awards(94)—
Payments and costs related to consolidated VIE settlement transaction(5,077)—
Distributions to subsidiary non-controlling interest(1,081)(50)
Net cash used in financing activities(10,721)(9,335)
Net increase (decrease) in cash and cash equivalents147,811(57,715)
Cash, cash equivalents, and restricted cash, beginning of period207,979213,792
Cash and cash equivalents of discontinued operations, beginning of period3015,702
Less: cash and cash equivalents of discontinued operations, end of period—(1,835)
Cash, cash equivalents, and restricted cash, end of period$356,091$159,944
Supplemental disclosure of cash flow information
Cash paid during the period for
Interest$32,556$41,121
Income taxes paid, net of (refunds)(48,796)121,009
Noncash investing and financing activities
ASC 842 lease additions - operating and finance leases$17,418$10,410
Purchases of property and equipment in accounts payable and accrued liabilities6,3022,682
Subordinate Voting Shares issued pursuant to redemption of non-controlling interest2,471—
Noncash partial extinguishment of construction finance liability—18,486
Reclassification of assets to held for sale7,044—
Adjustment of redeemable non-controlling interest to maximum redemption value6,945—

The condensed consolidated statements of cash flows include continuing operations and discontinued operations for the periods presented.

June 30,
20242023
Beginning of period:
Cash and cash equivalents (1)$201,372$207,185
Restricted cash6,6076,607
Cash, cash equivalents and restricted cash$207,979$213,792
End of period:
Cash and cash equivalents (2)$355,184$152,369
Restricted cash9077,575
Cash, cash equivalents and restricted cash$356,091$159,944

(1)Excludes cash associated with discontinued operations totaling$0.3 million and $5.7 million as of December 31, 2023 and 2022, respectively.

(2)Excludes cash associated with discontinued operations totaling zero and $1.8 million as of June 30, 2024 and 2023, respectively.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.